⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
STARHEALTH - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.4
| Stock Code | STARHEALTH | Market Cap | 30,700 Cr. | Current Price | 521 ₹ | High / Low | 587 ₹ |
| Stock P/E | 55.1 | Book Value | 163 ₹ | Dividend Yield | 0.00 % | ROCE | 8.57 % |
| ROE | 6.70 % | Face Value | 10.0 ₹ | DMA 50 | 496 ₹ | DMA 200 | 473 ₹ |
| Chg in FII Hold | 0.99 % | Chg in DII Hold | -0.65 % | PAT Qtr | 111 Cr. | PAT Prev Qtr | 128 Cr. |
| RSI | 60.8 | MACD | 7.20 | Volume | 8,27,382 | Avg Vol 1Wk | 6,06,728 |
| Low price | 413 ₹ | High price | 587 ₹ | PEG Ratio | -16.0 | Debt to equity | 0.05 |
| 52w Index | 62.4 % | Qtr Profit Var | 21,731 % | EPS | 9.47 ₹ | Industry PE | 42.8 |
📈 Chart & Trend Analysis
- Moving Averages: Current price (₹521) is above both 50 DMA (₹496) and 200 DMA (₹473), confirming bullish momentum.
- RSI: At 60.8, the stock is moderately strong, close to overbought territory.
- MACD: Positive (7.20), indicating bullish momentum continuation.
- Bollinger Bands: Price is near the upper band, suggesting strong buying pressure but risk of short-term pullback.
- Volume Trends: Current volume (8,27,382) is above 1-week average (6,06,728), showing strong participation.
📊 Momentum & Signals
- Short-term momentum: Positive, supported by MACD and price above moving averages.
- Support Zone: ₹510 – ₹515 (near-term support).
- Resistance Zone: ₹580 – ₹587 (recent highs and psychological barrier).
- Entry Zone: ₹515 – ₹525 (near support, bullish bias).
- Exit Zone: ₹580 – ₹587 (resistance levels).
📉 Trend Status
The stock is currently in an uptrend with bullish signals from MACD and price above moving averages. A breakout above ₹587 could extend the rally further, while RSI suggests caution for short-term traders.
✅ Positive
- Strong ROCE (8.57%) and ROE (6.70%) show improving efficiency.
- EPS of ₹9.47 reflects profitability.
- Quarterly PAT growth (₹111 Cr vs ₹128 Cr previous quarter) remains steady despite slight decline.
- Strong 52-week performance (62.4% index gain).
⚠️ Limitation
- High P/E ratio (55.1) compared to industry average (42.8), making valuation expensive.
- PEG ratio (-16.0) indicates weak growth valuation.
- No dividend yield (0.00%), limiting income appeal.
📰 Company Negative News
- DII holding decreased (-0.65%), showing reduced domestic institutional confidence.
- PAT declined slightly (₹111 Cr vs ₹128 Cr), showing earnings pressure.
🌟 Company Positive News
- FII holding increased (+0.99%), reflecting foreign investor support.
- Quarterly profit variation (+21,731%) highlights strong earnings recovery compared to prior losses.
🏦 Industry
- Industry PE at 42.8, lower than STARHEALTH’s 55.1, suggesting peers are cheaper.
- Health insurance sector benefits from rising demand for coverage and regulatory support, though profitability remains cyclical.
📌 Conclusion
STARHEALTH is in a bullish uptrend with strong technical signals but stretched valuations. Entry near ₹515 – ₹525 with exit around ₹580 – ₹587 is optimal for short-term traders. Long-term investors should weigh strong earnings recovery and FII support against high valuations and modest efficiency metrics.